// App-Quantinova.ai

1258 : Effects of Intravenous Golimumab, an Anti-TNFα Monoclonal Antibody, on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 1-Year Results of a Phase III Trial

Researchers

Presenter

  • Atul Deodhar

Principal Investigators

  • Diane Harrison

  • Elizabeth Hsia

  • Eric K H Chan

  • Shelly Kafka

  • Kim Hung Lo

  • Lilianne Kim

  • Chenglong Han

Medical Centers

  • University of Texas Medical School, Houston, TX.

  • Oregon Health and Science University, Portland, OR

  • Janssen Research and Development, LLC, Spring House, PA

  • Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA

  • Janssen Scientific Affairs, Horsham, PA

Locations

  • United States

Companies

  • JB Medical Ltd.

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • golimumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved